Latest period
$49.12B
YoY change
+32.0%
5Y CAGR
+8.6%
Peak year (2025)
$50.53B
Latest annual
$50.53B
Total Debt history chart for Merck & Co. (MRK) from 1985 to 2025
Latest: $50.53B
Total Debt growth chart for Merck & Co. (MRK) from 1985 to 2025
Latest: +32.0%
Total Debt history table for Merck & Co. (MRK) from 1985 to 2025
| 2025 | $50.53B | +32.0% | +$12.26B | ||
| 2024 | $38.27B | +5.5% | +$2.00B | ||
| 2023 | $36.27B | +13.4% | +$4.28B | ||
| 2022 | $31.98B | -7.6% | −$2.65B | ||
| 2021 | $34.63B | +3.6% | +$1.21B | ||
| 2020 | $33.42B | +22.2% | +$6.07B | ||
| 2019 | $27.35B | +8.9% | +$2.24B | ||
| 2018 | $25.11B | +2.9% | +$704.00M | ||
| 2017 | $24.41B | -1.7% | −$432.00M | ||
| 2016 | $24.84B | -5.9% | −$1.57B | ||
| 2015 | $26.41B | +23.4% | +$5.01B | ||
| 2014 | $21.40B | -14.6% | −$3.66B | ||
| 2013 | $25.06B | +21.8% | +$4.49B | ||
| 2012 | $20.57B | +17.4% | +$3.05B | ||
| 2011 | $17.52B | -2.1% | −$367.00M | ||
| 2010 | $17.88B | +2.3% | +$408.00M | ||
| 2009 | $17.47B | +180.0% | +$11.23B | ||
| 2008 | $6.24B | +8.7% | +$501.00M | ||
| 2007 | $5.74B | -16.0% | −$1.10B | ||
| 2006 | $6.84B | -15.6% | −$1.26B | ||
| 2005 | $8.10B | +17.8% | +$1.22B | ||
| 2004 | $6.87B | +1.1% | +$76.70M | ||
| 2003 | $6.80B | -20.5% | −$1.75B | ||
| 2002 | $8.55B | -3.6% | −$316.50M | ||
| 2001 | $8.87B | +28.1% | +$1.95B | ||
| 2000 | $6.92B | +15.3% | +$917.10M | ||
| 1999 | $6.00B | +56.1% | +$2.16B | ||
| 1998 | $3.85B | +71.0% | +$1.60B | ||
| 1997 | $2.25B | +27.6% | +$487.00M | ||
| 1996 | $1.76B | -1.9% | −$33.90M | ||
| 1995 | $1.80B | +38.9% | +$503.30M | ||
| 1994 | $1.29B | -54.8% | −$1.56B | ||
| 1993 | $2.86B | +116.3% | +$1.54B | ||
| 1992 | $1.32B | +58.7% | +$488.80M | ||
| 1991 | $832.10M | -9.3% | −$85.00M | ||
| 1990 | $917.10M | +106.0% | +$472.00M | ||
| 1989 | $445.10M | -26.0% | −$156.50M | ||
| 1988 | $601.60M | -40.9% | −$416.60M | ||
| 1987 | $1.02B | +88.4% | +$477.80M | ||
| 1986 | $540.40M | +7.9% | +$39.60M | ||
| 1985 | $500.80M | — | — |
- 2025$50.53B+32.0%
- 2024$38.27B+5.5%
- 2023$36.27B+13.4%
- 2022$31.98B-7.6%
- 2021$34.63B+3.6%
- 2020$33.42B+22.2%
- 2019$27.35B+8.9%
- 2018$25.11B+2.9%
- 2017$24.41B-1.7%
- 2016$24.84B-5.9%
- 2015$26.41B+23.4%
- 2014$21.40B-14.6%
- 2013$25.06B+21.8%
- 2012$20.57B+17.4%
- 2011$17.52B-2.1%
- 2010$17.88B+2.3%
- 2009$17.47B+180.0%
- 2008$6.24B+8.7%
- 2007$5.74B-16.0%
- 2006$6.84B-15.6%
- 2005$8.10B+17.8%
- 2004$6.87B+1.1%
- 2003$6.80B-20.5%
- 2002$8.55B-3.6%
- 2001$8.87B+28.1%
- 2000$6.92B+15.3%
- 1999$6.00B+56.1%
- 1998$3.85B+71.0%
- 1997$2.25B+27.6%
- 1996$1.76B-1.9%
- 1995$1.80B+38.9%
- 1994$1.29B-54.8%
- 1993$2.86B+116.3%
- 1992$1.32B+58.7%
- 1991$832.10M-9.3%
- 1990$917.10M+106.0%
- 1989$445.10M-26.0%
- 1988$601.60M-40.9%
- 1987$1.02B+88.4%
- 1986$540.40M+7.9%
- 1985$500.80M—
Total Debt values are taken from Merck & Co.'s reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Debt at Merck & Co. (MRK)
According to Merck & Co.'s latest reported financial statements, the company's latest reported total debt is $49.12B. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total debt for Merck & Co. (MRK) came in at $50.53B – surged 32.0% year-over-year.
Over 2020–2025 (5 years), Merck & Co. total debt expanded at a +8.6% compound annual rate, with mixed annual results across the window.
2025 marks the peak total debt at $50.53B, with the historical low of $445.10M recorded in 1989.
Merck & Co. Total Debt by Year
Merck & Co. Total Debt 2025: $50.53B
2025's total debt for Merck & Co. came in at $50.53B, surged 32.0% from 2024. This figure represents the highest annual value in the available history.
Merck & Co. Total Debt 2024: $38.27B
Merck & Co. posted total debt of $38.27B in 2024, grew 5.5% from 2023.
Merck & Co. Total Debt 2023: $36.27B
In 2023, Merck & Co. reported total debt of $36.27B, grew 13.4% from 2022.
Merck & Co. Total Debt 2022: $31.98B
Merck & Co. total debt in 2022 was $31.98B, declined 7.6% below 2021.
Merck & Co. Total Debt 2021: $34.63B
Merck & Co. total debt in 2021 was $34.63B.
See more financial history for Merck & Co. (MRK).
Sector peers by Total Debt
Healthcare peers of Merck & Co. (MRK), ranked by their latest total debt
| $78.39B | |
| $69.07B | |
| $54.60B | |
| $47.93B | |
| $42.50B | |
| $40.85B | |
| $29.70B | |
| $20.59B |
- $78.39B
- $69.07B
- $54.60B
- $47.93B
- $42.50B
- $29.70B
- $20.59B
Frequently asked questions
Merck & Co. (MRK) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation